304 related articles for article (PubMed ID: 15935002)
1. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
[TBL] [Abstract][Full Text] [Related]
2. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C lookback in Canada.
Goldman M; Long A
Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
[TBL] [Abstract][Full Text] [Related]
4. Recent Canadian experience with targeted hepatitis C virus lookback.
Goldman M; Patterson L; Long A
Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
[TBL] [Abstract][Full Text] [Related]
5. Blood recipient notification for hepatitis C in Prince Edward Island.
Van Til LD; Sweet LE
CMAJ; 2000 Jan; 162(2):199-202. PubMed ID: 10674052
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.
Vogt M; Lang T; Frösner G; Klingler C; Sendl AF; Zeller A; Wiebecke B; Langer B; Meisner H; Hess J
N Engl J Med; 1999 Sep; 341(12):866-70. PubMed ID: 10498458
[TBL] [Abstract][Full Text] [Related]
7. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
8. Characterization of HCV strains in an oncohematological pediatric department reveals little horizontal transmission but multiple introductions by un-screened blood products in the past.
Stikleryte A; Griskeviciene J; Magnius LO; Zagminas K; Norder H; Ambrozaitis A
J Med Virol; 2006 Nov; 78(11):1411-22. PubMed ID: 16998896
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of transfusion-associated hepatitis C in a children's hospital.
Luban NL; Colvin CA; Mohan P; Alter HJ
Transfusion; 2007 Apr; 47(4):615-20. PubMed ID: 17381619
[TBL] [Abstract][Full Text] [Related]
10. A Canadian hospital-based HIV/hepatitis C look-back notification program.
Heddle N; Kelton JG; Smaill F; Foss K; Everson J; Janzen C; Walker C; Jones M; Hammons D
CMAJ; 1997 Jul; 157(2):149-54. PubMed ID: 9238143
[TBL] [Abstract][Full Text] [Related]
11. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
[TBL] [Abstract][Full Text] [Related]
12. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992.
Wang A; Book WM; McConnell M; Lyle T; Rodby K; Mahle WT
Am J Cardiol; 2007 Oct; 100(8):1307-9. PubMed ID: 17920376
[TBL] [Abstract][Full Text] [Related]
14. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
[TBL] [Abstract][Full Text] [Related]
15. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the impact of public health notification of suspected transfusion-transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigations by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005.
Whitlock M; Lord S; Buxton JA; Doyle P; Bigham M
Transfusion; 2007 Aug; 47(8):1534-9. PubMed ID: 17655599
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection in Egyptian children: single centre experience.
El-Raziky MS; El-Hawary M; El-Koofy N; Okasha S; Kotb M; Salama K; Esmat G; El-Raziky M; Abouzied AM; El-Karaksy H
J Viral Hepat; 2004 Sep; 11(5):471-6. PubMed ID: 15357655
[TBL] [Abstract][Full Text] [Related]
18. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
19. Outcome of screening for hepatitis C virus infection based on risk factors.
Mallette C; Flynn MA; Promrat K
Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
[TBL] [Abstract][Full Text] [Related]
20. Late liver-related mortality from complications of transfusion-acquired hepatitis C.
Kamitsukasa H; Harada H; Tanaka H; Yagura M; Tokita H; Ohbayashi A
Hepatology; 2005 Apr; 41(4):819-25. PubMed ID: 15793849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
